Live Chat ×
Skip to main content

Going Back to the Start: EIAs for Clostridiodes Difficile Detection

From the 2020 Joint Annual Meeting (July 1, 2020)
Presented by Nicholas Moore, PhD, MLS(ASCP)CM
This session will provide a brief overview of Clostridiodes difficile infection and how—in 10 years—the pendulum in the clinical microbiology laboratory has swung away from PCR assays and is reverting back to EIAs for diagnosing C. difficile.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

  1. Provide a brief overview of the epidemiology of,and risk factors for development of Clostridiodes difficile infection.
  2. Compare and contrast different test methodologies utilized in the diagnosis of CDI.
  3. Review the current clinical practice guidelines for C. difficile.

CE ACCREDITATION
This recorded presentation is P.A.C.E. ® accredited. The instruction level for this activity is Intermediate. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of Microbiology will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.

LEVEL OF INSTRUCTION
This intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.